Quantcast

Latest Paracetamol Stories

2014-03-21 12:24:25

MUMBAI, India and BALTIMORE, March 21, 2014 /PRNewswire/ -- Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals Inc. has launched its Niacin Extended-Release Tablets USP, 500 mg, 750 mg, 1000 mg strengths having received final approval from the United States Food and Drug Administration (FDA) yesterday. Lupin's Niacin Extended-Release Tablets USP, 500 mg, 750 mg, 1000 mg strengths are the AB-rated generic...

2014-03-20 23:02:05

The Firm is evaluating Tylenol lawsuits on behalf of individuals who sustained serious and life-threatening liver injuries, allegedly due to the acetaminophen in Tylenol brand over-the-counter medications. New York, New York (PRWEB) March 20, 2014 Dozens of Tylenol lawsuits (http://www.tylenollawsuitclaims.com/ ) that claim the popular over-the-counter medications caused serious liver injuries continue to move forward in a multidistrict litigation underway in U.S. District Court, Eastern...

2014-03-16 23:01:50

The firm is evaluating Tylenol lawsuits on behalf of individuals who suffered serious liver damage following ingestion of a Tylenol-brand product. New York, New York (PRWEB) March 16, 2014 As Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) continue to move forward in U.S. Courts, Bernstein Liebhard LLP notes that a federal judge in New Jersey has ruled that a claim stemming from a 2009 Tylenol recall will be allowed to proceed. According to an Order issued on March 5, 2014, Judge...

2014-03-13 23:27:22

JDP Therapeutics Inc., a privately held specialty pharmaceutical company, is pleased to announce that the Company’s Investigational New Drug (IND) to conduct an initial Phase 3 clinical trial of JDP-205 in patients with acute urticaria associated with an acute allergic reaction has been cleared by the U.S. Food and Drug Administration (FDA). Blue Bell, PA (PRWEB) March 13, 2014 JDP Therapeutics Inc., a privately held specialty pharmaceutical company, is pleased to announce that the...

2014-03-13 08:29:55

BRIDGEWATER, New Jersey, March 13, 2014 /PRNewswire/ -- Helsinn Group, the company focused on building quality cancer care, is pleased to announce today that its U.S. subsidiary, Helsinn Therapeutics (U.S.), Inc., has been named as one of the 100 best places to work in New Jersey in a survey and award program conducted by NJBIZ which recognizes and honors the state's top employers who show a dedication to their employees' growth and quality of life. In 2009 Helsinn...

2014-03-12 08:30:24

Investigational Opioid Analgesic Incorporates Abuse-Deterrent Technology STAMFORD, Conn., March 12, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that a Phase 3 study of an investigational extended-release formulation of hydrocodone bitartrate met its primary efficacy endpoint by showing that patients with chronic low back pain treated with the once-daily analgesic agent experienced statistically significant reduction in pain compared with placebo (p=0.0016). This investigational...

2014-03-11 23:01:45

The Firm is now investigating Tylenol liver damage claims on behalf of individuals who were allegedly injured by a Tylenol brand product. New York, New York (PRWEB) March 11, 2014 Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) filed on behalf of individuals who were allegedly injured by the popular over-the-counter medications continue to mount in a federal multidistrict litigation now underway in U.S. District Court, Eastern District of Pennsylvania, Bernstein Liebhard LLP...

2014-03-07 16:22:47

NASHVILLE, Tenn., March 7, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that data from a recent study evaluating the efficacy and safety of Caldolor(®) (ibuprofen) Injection will be presented at the Pediatric Anesthesiology 2014 conference in Fort Lauderdale, Florida. The pediatric study met its primary endpoint demonstrating that Caldolor was associated with a statistically significant reduction in temperature within the first 2 hours of...

2014-03-05 23:28:24

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. Chicago, IL (PRWEB) March 05, 2014 The prescription drug safety center DrugNews.net is announcing new information on the site for patients taking the blood thinner Pradaxa. A new report shows a research institute responsible for testing the drug prior to FDA approval has been named in lawsuits alleging it caused internal...

2014-03-03 08:31:51

NASHVILLE, Tenn., March 3, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) today announced the acquisition of Vaprisol(®) from Astellas Pharma US, Inc. Vaprisol(®) is a patented, prescription brand indicated to raise serum sodium levels in hospitalized patients with hyponatremia. The product was developed and registered by Astellas and was commercially launched in 2006. It is one of two branded prescription products indicated for the treatment of hyponatremia....


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related